Satwinder Singh

Dr. Satwinder Singh

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2020 in International Journal of Information Technology
Verified
Journal Article
Closed access
PDF file
FIFayaz Itoo
Fayaz Itoo
MEMeenakshi
Meenakshi
SSSatwinder Singh
Satwinder Singh

7 November 2020 in Journal of The Institution of Engineers (India): Series B
Verified
Journal Article
Closed access
PDF file
RSRitika Singh
Ritika Singh
SSSatwinder Singh
Satwinder Singh

1 December 2018 in Ain Shams Engineering Journal
Verified
Journal Article
Open access
SSSatwinder Singh
Satwinder Singh
SKSharanpreet Kaur
Sharanpreet Kaur

10 November 2021 in Journal of King Saud University Computer and Information Sciences
Verified
Journal Article
Open access
SSSatwinder Singh
Satwinder Singh
HBHimanshu Beniwal
Himanshu Beniwal
Conversational AI intends for machine-human interactions to appear and feel more natural and inclined to communicate in a near-human context. Chatbots, also known as conversational agents, are typically divided into two types of use-cases: task-oriented bots and social friend-bots. Task-oriented bots are often used to do activities such as answering questions or solving basic queries. Furthermore, social-friend-bots are designed to communicate like humans, where the user can speak freely and the bot answers organically while maintaining the conversation’s ambience. This paper analyses recent works in the conversational AI domain examining the exclusive methodologies, existing frameworks or tools, evaluation metrics, and available datasets for building robust conversational agents. Finally, a mind-map encompassing all the stated elements and qualities of chatbots is created.

11 May 2022 in Biomedical Journal
Verified
Journal Article
Open access
GBGurjit Kaur Bhatti
Gurjit Kaur Bhatti
AGAnshika Gupta
Anshika Gupta
PPParas Pahwa
Paras Pahwa
NKNaina Khullar
Naina Khullar
SSSatwinder Singh
Satwinder Singh
JBJasvinder Singh Bhatti
Jasvinder Singh Bhatti
Mitochondria are the organelles that generate energy for the cells and act as biosynthetic and bioenergetic factories, vital for normal cell functioning and human health. Mitochondrial bioenergetics is considered an important measure to assess the pathogenesis of various diseases. Dysfunctional mitochondria affect or cause several conditions involving the most energy-intensive organs, including the brain, muscles, heart, and liver. This dysfunction may be attributed to an alteration in mitochondrial enzymes, increased oxidative stress, impairment of electron transport chain and oxidative phosphorylation, or mutations in mitochondrial DNA that leads to the pathophysiology of various pathological conditions, including neurological and metabolic disorders. The drugs or compounds targeting mitochondria are considered more effective and safer for treating these diseases. In this review, we make an effort to concise the available literature on mitochondrial bioenergetics in various conditions and the therapeutic potential of various drugs/compounds targeting mitochondrial bioenergetics in metabolic and neurodegenerative diseases.

20 September 2023 in Life Sciences
Verified
Journal Article
Open access
SBSrinjan Bhattacharya
Srinjan Bhattacharya
RMRahul Kumar Mahato
Rahul Kumar Mahato
SSSatwinder Singh
Satwinder Singh
GBGurjit Kaur Bhatti
Gurjit Kaur Bhatti
Sarabjit MastanaSarabjit Mastana
Sarabjit Mastana
JBJasvinder Singh Bhatti
Jasvinder Singh Bhatti
Thyroid cancer continues to exhibit a rising incidence globally, predominantly affecting women. Despite stable mortality rates, the unique characteristics of thyroid carcinoma warrant a distinct approach. Differentiated thyroid cancer, comprising most cases, is effectively managed through standard treatments such as thyroidectomy and radioiodine therapy. However, rarer variants, including anaplastic thyroid carcinoma, necessitate specialized interventions, often employing targeted therapies. Although these drugs focus on symptom management, they are not curative. This review delves into the fundamental modulators of thyroid cancers, encompassing genetic, epigenetic, and non-coding RNA factors while exploring their intricate interplay and influence. Epigenetic modifications directly affect the expression of causal genes, while long non-coding RNAs impact the function and expression of micro-RNAs, culminating in tumorigenesis. Additionally, this article provides a concise overview of the advantages and disadvantages associated with pharmacological and non-pharmacological therapeutic interventions in thyroid cancer. Furthermore, with technological advancements, integrating modern software and computing into healthcare and medical practices has become increasingly prevalent. Artificial intelligence and machine learning techniques hold the potential to predict treatment outcomes, analyze data, and develop personalized therapeutic approaches catering to patient specificity. In thyroid cancer, cutting-edge machine learning and deep learning technologies analyze factors such as ultrasonography results for tumor textures and biopsy samples from fine needle aspirations, paving the way for a more accurate and effective therapeutic landscape in the near future.